Using Non-Invasive Respiratory Monitoring for COVID-19 Pulmonary Embolism Diagnosis.

Area of Science:

• Pulmonary Medicine
• Critical Care Medicine
• Medical Technology

Background:

• COVID-19 significantly increases the risk of pulmonary embolism (PE) and pneumonia in hospitalized patients.
• Accurate and rapid diagnosis of respiratory distress etiology is critical for effective patient management.
• Traditional methods for diagnosing PE, like D-dimer tests and imaging, face challenges in the context of COVID-19's prothrombotic state and practicality concerns.

Observation:

• Severe respiratory distress in COVID-19 patients necessitates differentiating between PE and other causes like pneumonia.
• The prothrombotic nature of COVID-19 complicates diagnostic pathways for venous thromboembolism.
• Non-invasive respiratory monitoring technology presents a potential solution for assessing lung function and guiding diagnosis.

Findings:

• A case study demonstrated the successful diagnosis of PE in a COVID-19 patient using non-invasive respiratory monitoring.
• This technology aids in assessing lung function to determine the dominant cause of hypoxia.
• The method supports tailoring treatment strategies based on accurate etiological diagnosis.

Implications:

• Non-invasive respiratory monitoring can be a valuable tool for emergency departments managing COVID-19 patients with respiratory distress.
• It offers a practical and potentially more accessible alternative or adjunct to traditional diagnostic methods for PE.
• Implementing such technologies can lead to faster, more accurate diagnoses and improved patient outcomes in critical care settings.